Diasome
5 known investors
Find your way into Diasome
129 people in our graph can introduce you to the Diasome team.
Sign up to see every warm intro you have to Diasome
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Diasome team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Diasome develops metabolic therapies using its HDV platform to enable targeted drug delivery for treating diabetes, obesity, and metabolic diseases. The company focuses on translating therapeutic insights to restore metabolic function using endogenous mechanisms.
Founders & leadership

Investors · 5
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · biocentury.com · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements- Undisclosed amountseries A roundJul 2017
Medicxi (lead), Black Beret Life Sciences, JDRF, McDonald Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Diasome do?
- Diasome develops metabolic therapies using its HDV platform to enable targeted drug delivery for treating diabetes, obesity, and metabolic diseases. The company focuses on translating therapeutic insights to restore metabolic function using endogenous mechanisms.
- Who founded Diasome?
- Diasome was founded by Robert Geho, W. Blair Geho.
- Who are Diasome's investors?
- Diasome's investors include JDRF T1D Fund, Medicxi.
